The Wegovy 2.4mg click chart: what the clicks actually mean

The 2.4mg Wegovy pen is pre-filled and pre-set — the dose cannot be changed by the user; no manual clicking or dialling is needed before injecting.
Clicks heard during injection are the pen's internal mechanism working; the number varies slightly between pen designs but does not indicate how much medicine has been given.
2.4mg is the standard maintenance dose in Wegovy's titration schedule, reached after a series of 4-weekly increases prescribed by your clinician, it is not a starting dose.
If the plunger has fully depressed and the injection window (or indicator) shows the dose is complete, the pen has delivered correctly, consult the Patient Information Leaflet for the exact confirmation steps for your pen.

The Wegovy 2.4mg pen delivers a fixed 2.4mg dose of semaglutide in a single injection — there is no click-counting required from you. Each pen is pre-set at the factory; the number of clicks you hear during injection is a mechanical feature of how the pen ejects the medicine, not a dial you control. These are prescription-only medicines that must be assessed and prescribed by a clinician before use, so if you're unsure whether 2.4mg is the right stage for you, that conversation belongs with your prescriber. For anyone working through Wegovy's titration schedule, the full Wegovy pen clicks chart covers every strength from the starter dose upward.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What click-chart searches are really asking, and the accurate picture

The misconception: that you count clicks to measure the 2.4mg dose

Plenty of people search for a Wegovy click chart because they've heard that GLP-1 pens require the user to count clicks before injecting, the way some older insulin pens work when dialling a unit count. That is not how any Wegovy pen operates. Wegovy pens are auto-injectors: the dose is fixed and pre-loaded by the manufacturer. You do not set a dose, count a number, or stop at a specific click. The injection is complete when the plunger has fully depressed and the dose indicator confirms delivery, the detail of exactly what to look for is in the Patient Information Leaflet for your specific pen, and the Wegovy click chart UK guide walks through the pen-mechanics for each strength sold here.

This matters practically. If someone believes they need to count to a certain number and stops early, they may not receive the full dose. If they keep pushing past completion expecting more clicks, they risk damaging the pen or forcing air. Neither is what the pen is designed for. The mechanism is simpler than people expect: press, hold, done.

Wegovy's 2.4mg strength is the standard maintenance dose that most people reach after working through the earlier steps in the schedule, it is not where treatment begins. A prescriber decides when each step is appropriate; the Novo Nordisk product leaflet and your prescriber's instructions are the authorities on timing, not a click count.

How the 2.4mg pen actually works, the injection steps

Each Wegovy pen holds one dose. Once you remove it from the fridge and let it reach room temperature (the exact window is in the leaflet, follow that, not an estimate), you attach a new needle, check the liquid is clear and colourless, choose a clean injection site on your abdomen, thigh, or upper arm, and rotate away from last week's spot. Cleaning the skin first with an alcohol swab is straightforward and worth doing consistently.

When you press the pen against the skin and activate it, you may hear one or several clicks as the spring mechanism releases. This is entirely normal. What varies between pen formats is the sound, not the dose, a quieter click does not mean a smaller dose was given. Hold the pen in place for the number of seconds specified in your leaflet to allow the full volume to deliver; lifting it early is the more common user error. The needle guard will lock once the pen is removed, which is the cue that it's spent. Dispose of the used pen and needle in a sharps container rather than household waste.

The NHS medicines information for semaglutide provides a plain-language summary of the injection process; the NHS semaglutide page is a good first reference alongside your leaflet.

Where 2.4mg sits in Wegovy's titration schedule

Reaching 2.4mg is a process, not a starting point. The licensed schedule begins at 0.25mg, moves through 0.5mg, 1.0mg, and 1.7mg (each held for roughly four weeks) before arriving at 2.4mg as the standard maintenance dose. Some people stay longer at an intermediate strength if their prescriber judges it appropriate. If you're curious how the earlier steps compare, the 1.0mg pen guide covers the mechanics at that stage.

The STEP 1 trial (published in the New England Journal of Medicine) studied semaglutide at the 2.4mg maintenance dose and recorded an average body-weight reduction of around 15% over 68 weeks, alongside lifestyle support. That is the evidence base for the dose you're on or approaching. For context on how this compares to other options at the same maintenance stage, the guide to weight-loss injections and Ozempic explains the distinction between the diabetes and weight-management licensed products.

NICE recommended semaglutide (Wegovy) for weight management in its guidance TA875; eligibility criteria apply and are assessed during a clinical consultation. There is now also a higher 7.2mg maintenance dose approved by the MHRA (April 2026), with its own titration pathway, if that is relevant to your treatment, your prescriber will raise it. Pages covering other strengths such as the click chart for 1.0mg and the 1mg pen reference sit alongside this one if you're working through earlier stages.

For a broader look at how costs vary across the private market, the Wegovy prices guide sets out what to expect from a legitimate private prescription, including what a transparent price should cover.

When to contact your prescriber, not the click chart

A click chart can tell you how the pen works mechanically. It cannot tell you whether your dose is working, whether a side effect needs attention, or whether the schedule should change. Common side effects at 2.4mg are gastrointestinal (nausea, loose stools, reflux, or reduced appetite) and most settle within a couple of weeks of each new dose. If you find yourself putting the pen in your bag on a Tuesday morning before the school run and wondering whether last night's nausea was normal, that question goes to your prescriber, not a click count.

Seek urgent medical attention for severe or persistent stomach pain that radiates toward the back, which can occasionally indicate pancreatitis, the MHRA highlighted this as a known but infrequent risk in a January 2026 Drug Safety Update. You can also report suspected side effects directly through the MHRA Yellow Card scheme.

If you're considering starting Wegovy or want to review your current treatment, our prescribers are available seven days a week. Start your free consultation and a GPhC-registered Independent Prescriber will review your case the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions